top of page

WORK PACKAGE 4

The role of social costs in economic evaluations of health care decisions in Europe

Objectives
  • Identify the proportion of economic evaluation incorporating labour productivity losses and non-healthcare costs

  • Identify pathologies where it is more frequent to include social costs in economic evaluations

  • Identify the countries where it is more frequent the inclusion of social costs in economic evaluations

  • Compare the results of the economic evaluations achieved in case studies that incorporate social costs with the results of the studies not including social costs in the same studies

  • Identify the methodology used in the assessment of labour productivity losses, formal and informal care.

  • Elaborate a repository on unit costs in Europe of lost work time and the value of informal care time (coordinated part with WP3).

Methodology
  • Literature review: Revising the methodological aspects related to applied to the identification, measurement and valuation of social costs, especially, labour losses and informal care cost in economic evaluations

  • Case studies: Quantifying different ways of incorporating the social perspective into economic analysis to inform European decisions

  • European Database: Creating a database on unit costs in Europe of lost work time and the value of informal and formal care time (coordinated part with WP3).

Outputs
  • Deliverable D4.1: Revising the methodological aspects applied to the identification, measurement and valuation of social costs in economic evaluations [PDF]
     

  • Deliverable D4.2: How relevant is the societal perspective in economic evaluations? Evidence from five case studies [PDF]
     

  • Deliverable D4.3: Core dataset of social costs. Creating a database on unit costs in Europe of lost work time and the value of informal and formal care time of unit costs of health services [PDF]
     

  • Work Package Overall Results [Poster PDF]
     

  • European Healthcare and Social Cost Database (EU HCCD)

The EU HCCD provides a core dataset of costs across countries. It allows analysis of variations in costs within/across countries (taking into account differences between healthcare systems and other factors) and health economic evaluations (by transfer of economic evaluation analysis and models across countries). Additionally, it facilitates multi-country studies and the adaptation of economic evaluation studies from country to country by reducing the time/costs of finding healthcare costs.

Access the database HERE.

 

Publications

  • Aranda-Reneo I, Peña-Longobardo LM, Rodríguez-Sánchez B, Oliva-Moreno J, López-Bastida J. How relevant are social costs in economic evaluations? The case of Alzheimer’s disease, Jornadas de Economía de la Salud, 2019 [PDF]
     

  • Peña-Longobardo LM, Rodríguez-Sánchez B, Oliva-Moreno J, Aranda-Reneo I, López-Bastida J. (2019). How relevant are social costs in economic evaluations? The case of Alzheimer’s disease. The European Journal of Health Economics, 20(8), 1207–1236. [https://doi.org/10.1007/s10198-019-01087-6]
     

  • López-Bastida J, Aranda-Reneo I, Peña-Longobardo LM, Rodríguez-Sánchez B, Oliva-Moreno J. How relevant are social costs in economic evaluations? The case of Rare Diseases – ISPOR 2019 [Poster PDF]
     

  • Juliane Andrea Duevel, Lena Hasemann, Luz Maria Peña-Longobardo, Beatriz Rodríguez-Sánchez, Isaac Aranda-Reneo, Juan Oliva-Moreno, Julio López-Bastida, Wolfgang Greiner (2020). Considering the societal perspective in economic evaluations: a systematic review in the case of depression. Health Economics Review, 2020,10 (1):32 [https://doi.org/10.1186/s13561-020-00288-7]
     

  • López-Bastida J, Rodríguez-Sánchez B, Aranda-Reneo I, Oliva-Moreno J. Assessing the effect of including social costs in economic evaluations: A systematic review of diabetes-related interventions – ISPOR 2020 [Poster PDF]
     

  •  López-Bastida J, Düvel AJ, Hasemann L, Peña-Longobardo L.M, Rodríguez-Sánchez B, Aranda-Reneo I, Oliva-Moreno J, Greiner W. Considering the societal perspective in economic evaluations: a systematic review in the case of depression – ISPOR 2020 [Poster PDF]
     

  • López-Bastida J, Cichetti A, Rodríguez-Sánchez B, Daugberg S, Peña-Longobardo L.M, Aranda-Reneo I, Oliva-Moreno J. Social costs in multiple sclerosis economic evaluations: do their inclusion change the results and conclusions? A systematic review – ISPOR 2020 [Poster PDF]
     

  • Aranda-Reneo I, Rodríguez-Sánchez B, Peña-Longobardo LM, Oliva-Moreno J, López-Bastida J. Can the Consideration of Societal Costs Change the Recommendation of Economic Evaluations in the Field of Rare Diseases? An Empirical Analysis. Value Health. 2021 Mar;24(3):431-442. doi: 10.1016/j.jval.2020.10.014. Epub 2020 Dec 5. PMID: 33641778. [Read on PubMed]
     

  • Rodriguez-Sanchez B, Aranda-Reneo I, Oliva-Moreno J, Lopez-Bastida J. Assessing the Effect of Including Social Costs in Economic Evaluations of Diabetes-Related Interventions: A Systematic Review. Clinicoecon Outcomes Res. 2021 Apr 29;13:307–334. [https://doi.org/10.2147/ceor.s301589]

  • Rodríguez‑Sánchez B, Daugbjerg S, Peña‑Longobardo LM, Oliva‑Moreno J, Aranda‑Reneo I, Cicchetti A, López‑Bastida J (2022) Does the inclusion of societal costs change the economic evaluations recommendations? A systematic review for multiple sclerosis disease. The European Journal of Health Economics [https://doi.org/10.1007/s10198-022-01471-9]

Lead

University Castilla-La Mancha

Faculty of Health Science – Department of nursing, physical therapy and occupational therapy; Faculty of Law and Social Science – Department of Economic Analysis and Finance

Research team

Julio López Bastida (PI)

Beatriz Rodriguez Martín 

Juan Oliva Moreno

Luz Maria Peña Longobardo

Isaac Aranda Reneo 

Beatriz Rodriguez Sanchez

Álvaro Hidalgo Vega

bottom of page